Medications for Dementia

16 results
  • Bryant Ranch Prepack
    Usage: Donepezil hydrochloride is indicated for the treatment of Alzheimer's type dementia, showing efficacy in patients across all stages: mild, moderate, and severe.
  • Bryant Ranch Prepack
    Usage: Donepezil hydrochloride tablets are indicated for the treatment of Alzheimer's disease dementia, showing efficacy in patients with mild, moderate, and severe stages of the condition.
  • Preferred Pharmaceuticals Inc.
    Usage: Donepezil hydrochloride tablets are indicated for the treatment of Alzheimer’s type dementia, demonstrating efficacy in patients across mild, moderate, and severe stages of the disease.
  • Ranbaxy Pharmaceuticals Inc.
    Usage: Donepezil is indicated for the treatment of Alzheimer's disease-related dementia, with demonstrated efficacy in patients with mild, moderate, and severe forms of the condition.
  • Coupler LLC
    Usage: Donepezil hydrochloride is indicated for the treatment of Alzheimer's disease-related dementia, demonstrating efficacy in patients with mild, moderate, and severe forms of the condition.
  • Bora Pharmaceutical Laboratories Inc.
    Usage: Donepezil hydrochloride tablets are indicated for treating Alzheimer's-type dementia, showing efficacy in patients with mild, moderate, and severe stages of the disease.
  • Curium US LLC
    Usage: Ioflupane I 123 Injection is indicated as an adjunct for striatal dopamine transporter visualization via SPECT brain imaging in adults suspected of having Parkinsonian syndromes or dementia with Lewy bodies.
  • NCS HealthCare of KY, Inc dba Vangard Labs
    Usage: Memantine hydrochloride tablets are indicated for the treatment of moderate to severe Alzheimer's disease.
  • Zydus Pharmaceuticals USA Inc.
    Usage: Memantine hydrochloride extended-release capsules are indicated for treating moderate to severe dementia associated with Alzheimer's disease.
  • Amneal Pharmaceuticals of New York LLC
    Usage: Memantine hydrochloride tablets are indicated for the treatment of moderate to severe Alzheimer’s disease-related dementia.